Sino Biopharmaceutical (FRA:SMZ1) Inventories, Raw Materials & Components : €0 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Sino Biopharmaceutical Inventories, Raw Materials & Components?

Sino Biopharmaceutical's inventories, raw materials & components for the quarter that ended in Jun. 2023 was €0 Mil.

Sino Biopharmaceutical's quarterly raw materials increased from Jun. 2022 (€0 Mil) to Dec. 2022 (€110 Mil) but then declined from Dec. 2022 (€110 Mil) to Jun. 2023 (€0 Mil).

Sino Biopharmaceutical's annual raw materials declined from Dec. 2020 (€103 Mil) to Dec. 2021 (€81 Mil) but then increased from Dec. 2021 (€81 Mil) to Dec. 2022 (€110 Mil).

Sino Biopharmaceutical Inventories, Raw Materials & Components Historical Data

The historical data trend for Sino Biopharmaceutical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Inventories, Raw Materials & Components Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

84.05

103.12

80.93

110.09

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															80.93	-	110.09	-	-

Sino Biopharmaceutical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Sino Biopharmaceutical (FRA:SMZ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (FRA:SMZ1) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Sino Biopharmaceutical (FRA:SMZ1) Headlines

No Headlines